HCPCS Level II · Drugs administered other than oral method
J2806Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms
Terminated 12/31/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J2806
J2806 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms.
It was added to HCPCS effective 07/01/2023, and its current record took effect 01/01/2025.
It was terminated on 12/31/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj sincalide, maia, 5 mcg
- Date added
- 07/01/2023
- Action effective
- 01/01/2025
- Termination date
- 12/31/2024
- BETOS
- O1E
Related J28xx codes
- J2800Injection, methocarbamol, up to 10 ml
- J2801Injection, risperidone (rykindo), 0.5 mg
- J2802Injection, romiplostim, 1 microgram
- J2804Injection, rifampin, 1 mg
- J2805Injection, sincalide, 5 micrograms
- J2810Injection, theophylline, per 40 mg
- J2820Injection, sargramostim (gm-csf), 50 mcg
- J2840Injection, sebelipase alfa, 1 mg
- J2850Injection, secretin, synthetic, human, 1 microgram
- J2860Injection, siltuximab, 10 mg
- J2865Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg
Common questions about J2806
Is HCPCS J2806 still valid?
- No. J2806 was terminated on 12/31/2024.
Does Medicare cover J2806?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.